Acquisitions - Summary of Acquisition Date Fair Value of Provisional Consideration Transferred in Acquisition (Details) - USD ($) $ in Thousands |
Jul. 21, 2025 |
Apr. 01, 2025 |
|---|---|---|
| Evergreen Theragnostics | ||
| Business Combination [Line Items] | ||
| Cash consideration | $ 276,424 | |
| Fair value of contingent consideration | 43,042 | |
| Total purchase consideration | $ 319,466 | |
| Lantheus Biosciences Ltd | ||
| Business Combination [Line Items] | ||
| Cash consideration | $ 352,614 | |
| Fair value of contingent consideration | 27,000 | |
| Total purchase consideration | 379,614 | |
| Lantheus Biosciences Ltd | Preliminary Estimate | ||
| Business Combination [Line Items] | ||
| Cash consideration | 355,204 | |
| Fair value of contingent consideration | 27,000 | |
| Total purchase consideration | 382,204 | |
| Lantheus Biosciences Ltd | Measurement Period Adjustment | ||
| Business Combination [Line Items] | ||
| Cash consideration | (2,590) | |
| Fair value of contingent consideration | 0 | |
| Total purchase consideration | $ (2,590) |
| X | ||||||||||
- Definition Business combination consideration. No definition available.
|
| X | ||||||||||
- Definition Payment of working capital settlement in business combination. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|